國邑藥品科技股份有限公司
國邑藥品科技股份有限公司為生物技術公司，專注於在台灣開發新藥。研發 L606 吸入組合產品用於治療肺動脈高壓及間質性肺病相關肺高壓；以及 L608 用於治療肺血管疾病。公司成立於 2000 年，總部位於台灣台北市。
今日上漲 1.23%，股價站回短期均線。該股 RSI(6) 為 37.8，處於中性區間，短線無明顯超買超賣訊號。股價站上5日均線，跌破20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標中性（K=26.2）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 08-10 | -14 | 0 | 0 | -14 |
| 08-07 | -13 | 0 | 0 | -13 |
| 08-06 | -36 | 0 | 0 | -36 |
| 08-05 | -15 | 0 | +2 | -14 |
| 08-04 | +4 | 0 | 0 | +4 |
| 08-03 | -27 | 0 | 0 | -27 |
| 07-31 | +2 | 0 | 0 | +2 |
| 07-30 | +9 | 0 | 0 | +9 |
| 07-29 | -3 | 0 | 0 | -3 |
| 07-28 | -7 | 0 | 0 | -7 |
| 07-27 | -8 | 0 | 0 | -8 |
| 07-24 | -14 | 0 | 0 | -14 |
| 07-23 | -13 | 0 | 0 | -13 |
| 07-22 | -11 | 0 | 0 | -11 |
| 07-21 | -1 | 0 | 0 | -1 |
| 07-20 | -8 | 0 | 0 | -8 |
| 07-17 | -3 | 0 | 0 | -3 |
| 07-16 | -12 | 0 | 0 | -12 |
| 07-15 | +20 | 0 | 0 | +20 |
| 07-14 | -9 | 0 | +2 | -8 |
| 07-13 | +20 | 0 | 0 | +20 |
| 07-09 | -11 | 0 | 0 | -11 |
| 07-08 | -30 | 0 | 0 | -30 |
| 07-07 | +136 | 0 | 0 | +136 |
| 07-06 | +32 | 0 | 0 | +32 |
| 07-03 | +31 | 0 | 0 | +31 |
| 07-02 | +39 | 0 | 0 | +39 |
| 07-01 | +2 | 0 | 0 | +2 |
| 06-30 | -45 | 0 | 0 | -45 |
| 06-29 | +63 | 0 | 0 | +63 |
| 06-26 | +14 | 0 | 0 | +14 |
| 06-25 | -21 | 0 | 0 | -21 |
| 06-24 | +30 | 0 | +1 | +30 |
| 06-23 | +19 | 0 | 0 | +19 |
| 06-22 | +41 | 0 | 0 | +41 |
| 06-18 | +5 | 0 | 0 | +5 |
| 06-17 | +14 | 0 | 0 | +14 |
| 06-16 | +45 | 0 | 0 | +45 |
| 06-15 | +3 | 0 | 0 | +2 |
| 06-12 | +9 | 0 | 0 | +9 |
| 06-11 | +11 | 0 | 0 | +11 |
| 06-10 | -37 | 0 | +2 | -36 |
| 06-09 | -4 | 0 | 0 | -4 |
| 06-08 | +17 | 0 | +1 | +17 |
| 06-05 | +50 | 0 | 0 | +50 |
| 06-04 | -2 | 0 | 0 | -2 |
| 06-03 | +29 | 0 | 0 | +29 |
| 06-02 | -5 | 0 | +2 | -4 |
| 06-01 | -2 | 0 | 0 | -3 |
| 05-29 | -1 | 0 | 0 | -1 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/04 | 0 | -100.0% | - |
| 2026/03 | 179 萬 | - | - |
| 2026/02 | 0 | - | - |
| 2026/01 | 0 | -100.0% | - |
| 2025/12 | 201 萬 | -95.6% | -54.5% |
| 2025/11 | 4558 萬 | - | - |
| 2025/10 | 0 | - | -100.0% |
| 2025/09 | 0 | - | -100.0% |
| 2025/08 | 0 | -100.0% | - |
| 2025/07 | 400 萬 | - | - |
| 2025/06 | 0 | -100.0% | - |
| 2025/05 | 1568 萬 | - | +64.3% |